We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$619M
AUM Growth
+$611M
Cap. Flow
+$607M
Cap. Flow %
98.01%
Top 10 Hldgs %
54.74%
Holding
713
New
622
Increased
43
Reduced
2
Closed
4

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$110K
2
HSTM icon
HealthStream
HSTM
+$16.3K
3
PCAR icon
PACCAR
PCAR
+$12.5K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.38%
2 Financials 7.1%
3 Energy 6.16%
4 Healthcare 4.27%
5 Technology 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWY icon
351
iShares MSCI South Korea ETF
EWY
$21.7B
$23K ﹤0.01%
+375
New +$21.5K
KEY icon
352
KeyCorp
KEY
$24.3B
$23K ﹤0.01%
+2,060
New +$24.6K
NSC icon
353
Norfolk Southern
NSC
$78.8B
$23K ﹤0.01%
+300
New +$22.5K
SCCO icon
354
Southern Copper
SCCO
$141B
$23K ﹤0.01%
+899
New +$23.2K
USB.PRH icon
355
US Bancorp Series B Preferred Stock
USB.PRH
$746M
$23K ﹤0.01%
+1,159
New +$23.8K
SRE icon
356
Sempra
SRE
$60.8B
$22K ﹤0.01%
+500
New +$21.2K
AKZOY
357
DELISTED
Akzo Nobel NV
AKZOY
$22K ﹤0.01%
+999
New +$22K
USB.PRM
358
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$22K ﹤0.01%
+825
New +$22.1K
USB.PRN.CL
359
DELISTED
U.S. Bancorp
USB.PRN.CL
$22K ﹤0.01%
+825
New +$22.2K
DVN icon
360
Devon Energy
DVN
$51.9B
$21K ﹤0.01%
+372
New +$21.3K
GGN
361
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$21K ﹤0.01%
+2,000
New +$21.4K
PNY
362
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$21K ﹤0.01%
+620
New +$20.8K
EWZ icon
363
iShares MSCI Brazil ETF
EWZ
$9.05B
$20K ﹤0.01%
+425
New +$18.9K
LDOS icon
364
Leidos
LDOS
$14.1B
$20K ﹤0.01%
+1,250
New +$46.4K
LNC icon
365
Lincoln National
LNC
$7.91B
$20K ﹤0.01%
+472
New +$19.9K
AFL icon
366
Aflac
AFL
$63.9B
$19K ﹤0.01%
+600
New +$18.1K
BRO icon
367
Brown & Brown
BRO
$22.9B
$18K ﹤0.01%
+1,104
New +$18K
EXPD icon
368
Expeditors International
EXPD
$22.9B
$18K ﹤0.01%
+400
New +$16.6K
KOF icon
369
Coca-Cola Femsa
KOF
$21.6B
$18K ﹤0.01%
+141
New +$19.4K
RIG icon
370
Transocean
RIG
$5.92B
$18K ﹤0.01%
+415
New +$19.6K
D icon
371
Dominion Energy
D
$62.5B
$17K ﹤0.01%
+273
New +$16.2K
STBA icon
372
S&T Bancorp
STBA
$1.86B
$17K ﹤0.01%
+698
New +$16.2K
CFN
373
DELISTED
CAREFUSION CORPORATION
CFN
$17K ﹤0.01%
+448
New +$16.7K
RZA
374
DELISTED
REINSURANCE GROUP OF AMERICA, INCORPORATED 6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042
RZA
$17K ﹤0.01%
+700
New +$17.4K
GRA
375
DELISTED
W.R. Grace & Co.
GRA
$17K ﹤0.01%
+200
New +$16.6K

Similar funds

Hirtle Callaghan & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Hirtle Callaghan & Co held 713 positions worth $619M, up 7,069% from $8.64M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hirtle Callaghan & Co deployed $607M of net new capital in Q3 2013, opening 622 new positions and adding to 43 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 17% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was HealthStream, an estimated $16.3K trimmed.

  • Hirtle Callaghan & Co's largest Q3 2013 buy was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.
  • Hirtle Callaghan & Co added most to Philip Morris in Q3 2013, an estimated $77.6M increase.
  • Hirtle Callaghan & Co's biggest Q3 2013 reduction was HealthStream, cutting an estimated $16.3K.
  • Hirtle Callaghan & Co fully exited Community Health Systems in Q3 2013, selling an estimated $110K.
  • Hirtle Callaghan & Co's ten largest holdings make up 55% of its $619M portfolio in Q3 2013.
  • Hirtle Callaghan & Co opened 622 new positions and closed 4 in Q3 2013.
  • Hirtle Callaghan & Co's portfolio value rose 7,069% quarter-over-quarter to $619M.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2013, filed 12 Nov 2013.